Dr.ย Polinaย Stepensky
MD, Oncology
Director, Bone Marrow Transplantation & Cancer Immunotherapy
corporate_fareHadassah Medical Center, Jerusalem
Polina Stepensky
MD, Oncology
Prof. Polina Stepensky is Director of the Bone Marrow Transplantation Department at Hadassah Medical Center (Hadassah Ein Kerem), Jerusalem, one of Israel's foremost academic medical institutions. She specialises in haematopoietic stem cell transplantation, paediatric haemato-oncology, and advanced cancer immunotherapy, including CAR T-cell therapy for adults and children.
With more than 20 years of clinical and academic experience, Prof. Stepensky leads a department managing complex transplant cases for both children and adults with malignant and non-malignant haematologic disorders. Her advanced training included bone marrow transplantation fellowships at the University of Minnesota and Great Ormond Street Hospital in London, following her medical degree and paediatric residency at Hebrew University of Jerusalem and Hadassah. She also heads Hadassah's Bone Marrow Transplantation and Cancer Immunotherapy programme, with a notable focus on Hadassah-developed CAR T-cell approaches for multiple myeloma produced in collaboration with Bar-Ilan University. Prof. Stepensky has an outstanding academic record, with over 8,500 citations and an h-index of 47 on Google Scholar, covering HSCT, rare immune deficiencies, and post-transplant complications.
CancerFax can coordinate medical-report review and consultation support for international patients seeking access to Prof. Stepensky's expertise at Hadassah Medical Center.
Why Consider Prof. Polina Stepensky?
Prof. Stepensky combines departmental leadership in bone marrow transplantation with a pioneering role in cellular immunotherapy, offering patients access to highly specialised care within a leading Israeli academic centre.
Areas of Specialisation
Bone marrow transplantation, paediatric haemato-oncology, and advanced cellular immunotherapy
Prof. Stepensky's practice spans the full spectrum of haematopoietic stem cell transplantation for malignant and non-malignant conditions, CAR T-cell therapy, and the management of complex post-transplant complications in both children and adults.
Haematopoietic Stem Cell Transplantation
Core transplant expertise for a broad range of haematologic malignancies and rare inherited disorders in paediatric and adult patients.
- arrow_rightAllogeneic stem cell transplantation for malignant haematologic diseases
- arrow_rightBone marrow transplantation for children and adults
- arrow_rightTransplantation for rare non-malignant disorders including osteopetrosis and Wiskott-Aldrich syndrome
- arrow_rightDiagnosis and management of graft-versus-host disease
- arrow_rightPost-transplant autoimmune cytopenias and immune complications
- arrow_rightLong-term monitoring and follow-up for transplant recipients
CAR T-Cell Therapy & Cancer Immunotherapy
Advanced cellular therapy for selected haematologic malignancies, including Hadassah-developed investigational approaches.
- arrow_rightHBI0101 / NXC-201 BCMA-targeting CAR T-cell therapy under Phase II clinical evaluation (NCT06971380)
- arrow_rightPrincipal investigator on a Hadassah-led study in relapsed or refractory multiple myeloma and light-chain amyloidosis
- arrow_rightCellular immunotherapy approaches for haematologic cancers
- arrow_rightImmunotherapy integrated into multidisciplinary transplant programmes
Paediatric Haemato-Oncology
Dedicated expertise in blood cancers and haematologic disorders in children, including transplant-requiring rare conditions.
- arrow_rightStem cell transplantation for paediatric haematologic malignancies and leukaemia
- arrow_rightBone marrow transplantation for inherited immune and metabolic disorders in children
- arrow_rightManagement of complications specific to paediatric transplant recipients
Procedures Performed
Stem cell transplantation, cellular therapy, and complex haematology services
Prof. Stepensky's clinical programme covers allogeneic stem cell transplantation, CAR T-cell administration, and comprehensive management of transplant-related complications for both paediatric and adult patients.
Haematopoietic Stem Cell Transplantation
TransplantAllogeneic bone marrow and stem cell transplantation for malignant and non-malignant haematologic conditions in children and adults.
CAR T-Cell Therapy
Medical OncologyChimeric antigen receptor T-cell therapy for eligible patients with relapsed or refractory haematologic malignancies.
Post-Transplant & Complication Management
MonitoringOngoing management of transplant-related complications, immune reconstitution monitoring, and long-term follow-up care.
Second Opinion for Complex Cases
Second OpinionExpert review for patients with complex haematologic malignancies, rare disorders, or prior transplant complications.
Research & Publications
Peer-reviewed contributions in haematopoietic transplantation and cellular immunotherapy
Prof. Stepensky has an internationally recognised research profile with over 8,500 citations and an h-index of 47 on Google Scholar. Her PubMed-indexed work spans haematopoietic stem cell transplantation, rare paediatric disorders, primary immune deficiencies, and post-transplant complications.
A full publication list is available on Google Scholar (h-index 47, 8,500+ citations). Further details may be requested through Hadassah Medical Center.
Education & Training
Prof. Stepensky completed her medical education at the Hebrew University of Jerusalem and trained in paediatrics and bone marrow transplantation at Hadassah Medical Center, the University of Minnesota, and Great Ormond Street Hospital in London.
Clinical Experience
Prof. Stepensky has spent her career at Hadassah Medical Center in Jerusalem, progressing from residency and specialisation training to her current leadership role as Director of the Bone Marrow Transplantation Department and head of the cancer immunotherapy programme for adults and children.
Languages & International
Prof. Stepensky consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients consulting through Hadassah Medical Center.
CancerFax can coordinate professional medical interpreter support for international patients requiring consultation in additional languages.
How CancerFax Helps You Access Dr. Polina Stepensky
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Polina Stepensky's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Polina Stepensky's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Polina Stepensky before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Polina Stepensky's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Polina Stepensky's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Polina Stepensky's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Polina Stepensky
Prof. Polina Stepensky specialises in haematology, paediatric haemato-oncology, haematopoietic stem cell transplantation (HSCT), and cancer immunotherapy. She is Director of the Bone Marrow Transplantation Department at Hadassah Medical Center in Jerusalem, Israel.
Prof. Stepensky is based at Hadassah Medical Center, specifically Hadassah Ein Kerem in Jerusalem, Israel. Hadassah's official listing confirms her role as Director of the Bone Marrow Transplantation Department.
Yes. Prof. Stepensky treats both paediatric and adult patients. Hadassah's official profile lists her clinical field as paediatrics and paediatric haemato-oncology, and she leads the department for bone marrow transplantation and cancer immunotherapy for adults and children.
Yes. Hadassah International identifies Prof. Stepensky as head of Hadassah's Bone Marrow Transplantation and Cancer Immunotherapy department and reports her involvement in Hadassah's CAR T-cell therapy programme for multiple myeloma. She is also the responsible party for a Phase II clinical trial (NCT06971380) evaluating HBI0101 / NXC-201 BCMA CAR T-cell therapy in relapsed or refractory multiple myeloma and light-chain amyloidosis.
International patients may seek evaluation through CancerFax, which can coordinate medical-report submission and consultation support with Hadassah Medical Center, subject to hospital availability and case acceptance. Specific documentation requirements and appointment timelines should be confirmed directly with Hadassah.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, and relevant test results. The CancerFax team will prepare and coordinate the case for submission to Hadassah Medical Center. The final consultation format depends on the hospital's availability and the nature of the case.
Connect with Polina Stepensky Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.